DERM

Journey Medical Corporation (DERM)

About Journey Medical Corporation (DERM)

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Details

Daily high

$6.89

Daily low

$6.17

Price at open

$6.50

52 Week High

$8.11

52 Week Low

$2.65

Market cap

135.3M

Dividend yield

0.00%

Volume

112,779

Avg. volume

56,237

P/E ratio

-694.68

Journey Medical Corporation News